Vitiligo - Epidemiology Forecast to 2027

  • ID: 4410581
  • Report
  • 80 Pages
  • DelveInsight
UP TO OFF
until Dec 31st 2018
1 of 3
‘Vitiligo - Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Vitiligo in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered:
  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan
Study Period: 2016-2027

Vitiligo Epidemiology

The Vitiligo epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Vitiligo are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Vitiligo Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [segmented by Prevalent population, Sex specific cases, Diagnosed Cases, Type Specific Diagnosed cases (segmental, non-segmental and unclassified) and Age Specific cases] scenario of Vitiligo in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According this research, the total prevalent population of Vitiligo was found to be 61, 36,840 in the year 2016.

Report Scope
  • The report covers detailed overview of Vitiligo explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Vitiligo in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by type i.e., Non-segmental, segmental and unclassified vitiligo, age and sex specific cases in 7MM.
Key strengths
  • 10 Year Forecast of Vitiligo
  • 7MM Coverage
  • Total Prevalent Cases of Vitiligo
  • Prevalent Cases according to segmentation: Sex Specific cases, Type Specific Diagnosed Prevalent cases and Age Specific cases of Vitiligo
Key assessments
  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Key Insights

2. Vitiligo Patient Share at a Glance
2.1. Patient Share (%) Distribution of Vitiligo in 2016
2.2. Patient Share (%) Distribution of Vitiligo in 2027

3. Disease Background and Overview: Vitiligo
3.1. Introduction
3.2. Types of Vitiligo
3.3. Causes of Vitiligo
3.4. Symptoms of Vitiligo
3.5. Pathophysiology
3.6. Diagnosis

4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Population and Forecast Parameters
4.3. Prevalent Population of Vitiligo in 7MM

5. Country Wise-Epidemiology of Vitiligo

6. United States
6.1. Assumptions and Rationale
6.2. Prevalent Population of Vitiligo in the United States
6.3. Sex Specific Prevalent Population of Vitiligo in the United States
6.4. Diagnosed Cases of Vitiligo in the United States
6.5. Type Specific Diagnosed Prevalent cases of Vitiligo in the United States
6.6. Age Specific Prevalent cases of Vitiligo in the United States

7. EU-5
7.1. Assumptions and Rationale

8. Germany
8.1. Prevalent Population of Vitiligo in Germany
8.2. Sex Specific Prevalent Population of Vitiligo in Germany
8.3. Diagnosed Cases of Vitiligo in Germany
8.4. Type Specific Diagnosed Prevalent cases of Vitiligo in Germany
8.5. Age Specific Prevalent cases of Vitiligo in Germany

9. France
9.1. Prevalent Population of Vitiligo in France
9.2. Sex Specific Prevalent Population of Vitiligo in France
9.3. Diagnosed Cases of Vitiligo in France
9.4. Type Specific Diagnosed Prevalent cases of Vitiligo in France
9.5. Age Specific Prevalent cases of Vitiligo in France

10. Italy
10.1. Prevalent Population of Vitiligo in Italy
10.2. Sex Specific Prevalent Population of Vitiligo in Italy
10.3. Diagnosed Cases of Vitiligo in Italy
10.4. Type Specific Diagnosed Prevalent cases of Vitiligo in Italy
10.5. Age Specific Prevalent cases of Vitiligo in Italy

11. Spain
11.1. Prevalent Population of Vitiligo in Spain
11.2. Sex Specific Prevalent Population of Vitiligo in Spain
11.3. Diagnosed Cases of Vitiligo in Spain
11.4. Type Specific Diagnosed Prevalent cases of Vitiligo in Spain
11.5. Age Specific Prevalent cases of Vitiligo in Spain

12. United Kingdom
12.1. Prevalent Population of Vitiligo in the United Kingdom
12.2. Sex Specific Prevalent Population of Vitiligo in the United Kingdom
12.3. Diagnosed Cases of Vitiligo in the UK
12.4. Type Specific Diagnosed Prevalent cases of Vitiligo in the United Kingdom
12.5. Age Specific Prevalent cases of Vitiligo in the UK

13. Japan
13.1. Assumptions and Rationale
13.2. Prevalent Population of Vitiligo in Japan
13.3. Sex Specific Prevalent Population of Vitiligo in Japan
13.4. Diagnosed Cases of Vitiligo in Japan
13.5. Type Specific Diagnosed Prevalent cases of Vitiligo in Japan
13.6. Age Specific Prevalent cases of Vitiligo in Japan

14. Unmet needs

15. Factors driving Vitiligo market

16. Factors restraining Vitiligo market

17. Appendix

18. Report Methodology
18.1. Sources Used

19. The Publisher Capabilities

20. Disclaimer

21. About the publisher
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll